Centenial Surgical Suture Share Price

CMP as on12-Oct-20 14:42

₹ 35.50
-1.85 -4.95%

Open

₹ 35.50

Turnover (lac)

Prev. Close

₹ 37.35

Day's Vol (shares)

₹ 8

Day's Range

₹ 35.50
₹ 35.50

Corporate Action

Go
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 03-Aug-2020 - -
CENTENIAL SURGICAL SUTURE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2020 ,inter alia, to consider and approve The meeting of Board of Directors of the Company CENTENIAL SURGICAL SUTURE LTD. will be held on Monday, August 10, 2020 to transact the following business: 1). To approve the Standalone Un-Audited Financial Results for the quarter ended June 30, 2020. 2). To approve the Book-closure dates as per Regulation 42 of the SEBI (LODR) Regulations, 2015 for the purpose of 25th Annual General Meeting of the Company. 3). To fix the Date, Time and Venue for convening 25th Annual General Meeting of the Members of the Company and approve the Draft Notice for the same. 4). Any other business with the permission of chair. The Board of Directors of the Company at their meeting held on Monday, the August 10, 2020 approved the following: 1). Approval of Standalone Un-Audited Financial Results for the quarter ended June 30, 2020 as per Reg 33 of SEBI (LODR) Regulations, 2015. 2). Re-appointment of Anuradha Kashikar, DIN : 00804831 Executive Director of the Company for further period of 03 years from April 1, 2021 to March 31, 2024, subject to approval of shareholders at the ensuing 25th Annual General Meeting (25th AGM). 3). Notice of 25th AGM along with Directors & Annual Report for the FY 2019 - 2020 & Venue, Day, Date & time of the 25th AGM. 4). Dates of closure of the Share Transfer Books & Register of Members as per Reg 42 (2) of the SEBI (LODR) Regulations, 2015 for the purpose of 25th AGM to be held on Monday the September 28, 2020. 5). Fixation of Cut-off date to record the entitlement of the Shareholders to cast their votes at the 25th AGM. The meeting was started at 3.00 pm & concluded at 5.30 pm Pursuant to Regulation 30 read with Schedule III Part A Para A (7) of SEBI (LODR) Regulations, 2015, we hereby inform you that the Board of Directors of the Company at its meeting held on August 10, 2020, pursuant to the recommendation of the Nomination and Remuneration Committee, have approved the re-appointment of Anuradha Kashikar (DIN : 00804831), Executive Director of the Company for a further period of 03 (Three) years w.e.f. April 1, 2021 subject to approval of shareholder at the ensuing 25th Annual General Meeting of the Company. (AS Per BSE Announcement Dated on 10.08.2020)
Board Meeting - 22-Jun-2020 - -
CENTENIAL SURGICAL SUTURE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/06/2020 ,inter alia, to consider and approve 1). To consider and take on record the Standalone Audited Financial Results for the quarter and year ended March 31, 2020. 2). To approve the Statement of Assets and Liabilities for the half year ended March 31, 2020. 3). Any other business with the permission of chair. Further, the Company will not be publishing the notice with respect to the Board Meeting in the newspaper under Regulation 47 of the SEBI (LODR) Regulations, 2015 in view of the relaxation granted by SEBI vide Circular No. SEBI/HO/CFD/CMDI/CIR/P/2020/79 dated May 12, 2020. The notice of the said Board Meeting will also be uploaded on the Companys website : www.centenialindia.com as per Regulation 46(2)(1)(i) of the Listing Regulations. The approved results will be uploaded on BSE Limited website after conclusion of the said meeting. The Board of Directors of the Company at their meeting held on June 30, 2020 approved the following: 1). Approval of Standalone Audited Financial Results for the quarter & year ended 31/03/2020 as per Regulation 33 of SEBI (LODR) Regulations, 2015. 2). Approval of Statement of Assets & Liabilities, Statement of Cash Flow for the year ended March 31, 2020. 3). Also note that Statutory Auditors of the Company have issued the Auditors Report for the financial year ended 31/03/2020 with unmodified opinion pursuant to Regulation 33(3)(d) of the SEBI(LODR) Reg, 2015. In accordance with SEBI circular dated May 12, 2020 bearing Ref. No. EBI/HO/CFD/CMD1/CIR/P/2020/79 granting relaxation from the provisions of Regulation 47 of the SEBI LODR, the Standalone AFR will not be published in the newspapers. However, the Standalone AFR as enclosed with this letter will be available on the Companys website Further, please note that the said meeting commenced at 16:30 p.m. and concluded at 17:15 p.m. (As per BSE Announcement Dated on 30/06/2020)
Board Meeting - 19-Feb-2020 - -
With reference to the above captioned subject, the Board of Directors of the Company at their meeting held on Wednesday, the February 19, 2020 at 6.30 p.m. has approved the following: 1. Approval of Notice of Postal Ballot seeking consent of the Members for approval of appointment of M/s.Mahesh Chandra & Associates, Chartered Accountants, Firm Registration No. 112334W having its Registered Office at 601/603, Dheeraj Savera Tower, Khatau Mills Compound, Off Western Express Highway, Borivali (East), Mumbai 400066, MAHARASHTRA as Statutory Auditors of the Company to fill the casual vacancy caused by the resignation of M/s.A. Vijay Kumar & Co., Chartered Accountants. 2. Approval of Resignation of M/s.A. Vijay Kumar & Co., Chartered Accountants, existing Statutory Auditor of the Company. 3. Approval of Calendar of events for conducting the Postal Ballot seeking approval of the members. The meeting was concluded at 7.15 p.m. Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements [LODR]) Regulations, 2015 or any other applicable provisions, we wish to inform you that the Board of Directors of the Company in their meeting held on Today, Wednesday the February 19, 2020, has approved appointment of M/s. Mahesh Chandra & Associates, Chartered Accountants (Firm Registration No. 112334W) as the Statutory Auditors of the Company. The Company will seek approval of the Members on the said appointment through Postal Ballot and M/s.Mahesh Chandra & Associates will hold office up to the conclusion of the 25th Annual General Meeting of the Company to be held in the calendar year 2020.
Board Meeting - 24-Jan-2020 - -
CENTENIAL SURGICAL SUTURE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2020 ,inter alia, to consider and approve 1). To approve the Standalone Un-Audited Financial Results for the quarter and nine months ended December 31, 2019. 2). Any other business with the permission of chair. In compliance of provisions of Regulation 47 (3) of the SEBI (LODR) Regulations, 2015, we hereby enclosed copy of the Free Press Journal (English) and Navshakti (Marathi) Newspaper both dated January 25, 2020 in which notices for intimation of Board meeting scheduled on February 6, 2020 to consider Standalone Un-Audited Financial Results for the quarter and nine months ended December 31, 2019. (As Per BSE Announcement Dated 25.01.2020) The Board of Directors of the Company at their meeting held on Thursday, the February 6, 2020 at 12.00 noon approved the following: 1). Approval of Standalone Un-Audited Financial Results for the quarter and nine months ended December 31, 2019 as per Regulation 33 of SEBI (LODR) Regulations, 2015. 2). Approval of Limited Review Report for the quarter and nine months ended December 31, 2019. The meeting was concluded at 12.45 p.m. You are requested to kindly take the same on your record. In pursuance of Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit following documents: 1). Standalone Un-Audited Financial Results for the quarter and nine months ended December 31, 2019. 2). Limited Review Report for the quarter and nine months ended December 31, 2019. You are requested to kindly take the same on your record. (As Per BSE Announcement dated on 06/02/2020)
Board Meeting - 01-Nov-2019 - -
Quarterly Results Inter alia, to consider and approve the following: 1. Re-appointment of Shri Devraj T. Poojary, (DI..: 02041726) Whole Time Director of the Company for the further period of 03 (Three) years w.e.f. February 1, 2020 subject to approval of shareholders in the shareholders meeting. 2. Any other business with the permission of chair. This is to inform you that the Board of Directors of the Company at their meeting held on Tuesday the November 12, 2019 at 11.30 p.m. approved the following: 1). Standalone Un-Audited Financial Results for the quarter and half year ended September 30, 2019 as per Regulation 33 of SEBI (LODR) Regulations, 2015. 2). Statement of Assets and Liabilities for the half year ended September 30, 2019. 3). Statement of Cash Flow for the half year ended September 30, 2019. 4). Related party transaction for the half year ended September 30, 2019. 5). Re-appointment of Shri Devraj T. Poojary, (DIN: 02041726), Whole Time Director of the company for a further period of 03 (Three) years i.e. from February 1, 2020 to January 31, 2023, subject to the approval of the shareholders of the Company. The meeting was concluded at 12.50 p.m. In pursuance of Regulation 33 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, we hereby submit following documents: 1). Standalone Un-Audited Financial Results for the quarter and half year ended September 30, 2019. 2). Statement of Assets and Liabilities for the half year ended September 30, 2019. 3). Statement of Cash Flow for the half year ended September 30, 2019. 4). Limited Review Report for the quarter and half year ended September 30, 2019. Pursuant to Regulation 30 read with Schedule III Part A Para A (7) of SEBI (LODR) Regulations, 2015, we hereby inform you that the Board of Directors of the Company at meeting held on November 12, 2019, pursuant to the recommendation of the Nomination and Remuneration Committee, have approved the Re-appointment of Shri Devraj T. Poojary, (DIN: 02041726), Whole Time Director of the Company for a further period of 03 year w.e.f. February 1, 2020 subject to the approval of the shareholders of the Company. (As Per BSE Announcement Dated 12.11.2019)